Form 4: Recursion Pharmaceuticals Director Acquires Shares Under Compensation Policy

Director Zavain Dar acquired 2,229 shares of Recursion Pharmaceuticals' Class A Common Stock on October 1, 2024, under the company's Outside Director Compensation Policy.

Summary

• On October 1, 2024, Zavain Dar, a director of Recursion Pharmaceuticals, acquired 2,229 shares of Class A Common Stock.
• The acquisition was made under the Issuer's Outside Director Compensation Policy.
• The price per share was $0.
• Following the transaction, Dar directly owns 106,225 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares under a compensation plan is generally a good sign, indicating alignment with company performance.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.

Industry Context

Director share acquisitions are common and often tied to compensation policies, aligning director interests with shareholder value.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates